In recent years, several molecular mechanisms involved in promoting cancer cell survival and growth have been identified. These discoveries helped in designing and testing novel drugs that target specific cellular pathways. In this review, we focus on new molecular targets that are currently being explored for the treatment of non-Hodgkin's lymphoma and Hodgkin's lymphoma.
|Original language||English (US)|
|Number of pages||11|
|Journal||Current hematology reports|
|State||Published - Jan 1 2005|
ASJC Scopus subject areas